IL2 and nonpapillary renal cell carcinoma: Tregs are known to be major inhibitors of effective immune responses in ccRCC, suppressing CD8+ T cell activation via cytokines such as transforming growth factor-β and interleukin 10, and depleting Interleukin 2 to block clonal expansion (69, 70).